13F

Stock

Crispr Therapeutics Ag

CRSP · held by 9 managers

Reported value

$19.9M

Holders

9

+0 new · −0 exited

Holders’ est. mark

−$621.1K

Price effect on 6 books still in the name

Largest holder

$15.5M

NORGES BANK

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
NORGES BANK456.1K$15.5MHeld
BARCLAYS PLC89.6K$3.05M−$477.7KCut−$967K
Marex Group plc18.8K$639.5K−$100.2KCut−$303.8K
Norris Financial Group, LLC9.68K$329.3K−$35KAdded$70.9K
Sanctuary Advisors, LLC8.63K$293.7KHeld
Evelyn Partners Investment Management LLP1.3K$44.2K−$6.93KCut−$6.93K
Medallion Wealth Advisors, LLC124$4.11K−$771Cut−$771
DANSKE BANK A/S100$3.4K−$533Cut−$533
Nalls Sherbakoff Group, LLC7$238Held

Positions as of Q1 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.